Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective neurodegeneration in Huntington's disease.

Literature DB >> 8526454

Selective neurodegeneration in Huntington's disease.

R L Albin.

Abstract

Entities: Disease

Mesh：

Year: 1995 PMID： 8526454 DOI： 10.1002/ana.410380602

Source DB: PubMed Journal: Ann Neurol ISSN： 0364-5134 Impact factor: 10.422

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.

Authors: John P Miller; Jennifer Holcomb; Ismael Al-Ramahi; Maria de Haro; Juliette Gafni; Ningzhe Zhang; Eugene Kim; Mario Sanhueza; Cameron Torcassi; Seung Kwak; Juan Botas; Robert E Hughes; Lisa M Ellerby
Journal: Neuron Date: 2010-07-29 Impact factor: 17.173

2. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease.

Authors: Zhihong Guo; Gay Rudow; Olga Pletnikova; Kari-Elise Codispoti; Brent A Orr; Barbara J Crain; Wenzhen Duan; Russell L Margolis; Adam Rosenblatt; Christopher A Ross; Juan C Troncoso
Journal: Mov Disord Date: 2012-09-13 Impact factor: 10.338

3. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Authors: C M Kipps; A J Duggins; N Mahant; L Gomes; J Ashburner; E A McCusker
Journal: J Neurol Neurosurg Psychiatry Date: 2005-05 Impact factor: 10.154

Review 4. Dysphagia in Huntington's disease: a review.

Authors: Anne-Wil Heemskerk; Raymond A C Roos
Journal: Dysphagia Date: 2010-09-14 Impact factor: 3.438

Review 5. Huntington disease models and human neuropathology: similarities and differences.

Authors: Jean Paul G Vonsattel
Journal: Acta Neuropathol Date: 2007-11-03 Impact factor: 17.088

6. Deep brain stimulation of the internal pallidum in Huntington's disease patients: clinical outcome and neuronal firing patterns.

Authors: Cécile Delorme; Alister Rogers; Brian Lau; Hélène Francisque; Marie-Laure Welter; Sara Fernandez Vidal; Jérôme Yelnik; Alexandra Durr; David Grabli; Carine Karachi
Journal: J Neurol Date: 2015-11-14 Impact factor: 4.849

Selective neurodegeneration in Huntington's disease.

1. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.

2. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease.

3. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Review 4. Dysphagia in Huntington's disease: a review.

Review 5. Huntington disease models and human neuropathology: similarities and differences.

6. Deep brain stimulation of the internal pallidum in Huntington's disease patients: clinical outcome and neuronal firing patterns.

7. Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease.

8. Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients.

Review 9. Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.

Review 10. MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?